The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Targeting ecto-5'-nucleotidase: A comprehensive review into small molecule inhibitors and expression modulators.EBI
Federal University of Rio Grande Do Sul
Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates EBI
Calithera Biosciences
Discovery and optimization of betulinic acid derivatives as novel potent CD73 inhibitors.EBI
The Second Military Medical University
Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors.EBI
Arcus Biosciences
Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production.EBI
Oric Pharmaceuticals
Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor.EBI
Ningxia Medical University
Discovery of AB680: A Potent and Selective Inhibitor of CD73.EBI
Arcus Biosciences